Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer

BACKGROUND: Capecitabine and paclitaxel are established effective treatments, alone and combined with other cytotoxic and targeted agents, for metastatic breast cancer (MBC). Paclitaxel polyglumex (a macromolecular conjugate of paclitaxel bound to poly-L-glutamic acid) has potential advantages over...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Northfelt, DW, Allred, JB, Liu, H, Hobday, TJ, Rodacker, MW, Lyss, AP, Fitch, TR, Perez, EA
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3593738/
https://ncbi.nlm.nih.gov/pubmed/23211220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e31826e0550
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items